HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kendra M Hasebroock Selected Research

Kendra M Hasebroock Research Topics

Disease

3Neoplasms (Cancer)
02/2011 - 01/2009
2Lupus Nephritis
01/2012 - 05/2010
1Glomerulonephritis
01/2012
1Lung Neoplasms (Lung Cancer)
02/2011
1Body Weight (Weight, Body)
02/2011
1Carcinogenesis
02/2011
1Cysts
11/2010
1Colorectal Neoplasms (Colorectal Cancer)
06/2010
1Inflammation (Inflammations)
05/2010
1Nephrogenic Fibrosing Dermopathy
04/2009
1Prostatic Neoplasms (Prostate Cancer)
01/2009
1Glioma (Gliomas)
01/2009
1Breast Neoplasms (Breast Cancer)
01/2009

Drug/Important Bio-Agent (IBA)

2Contrast MediaIBA
01/2012 - 04/2009
1Complement C3 (C3 Complement)IBA
01/2012
1Biomarkers (Surrogate Marker)IBA
01/2012
1Complement Receptors (Complement Receptor)IBA
01/2012
1Silybin (Lagosa)IBA
02/2011
1NestinIBA
02/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2011
1Urethane (Ethyl Carbamate)IBA
02/2011
1interleukin-24 (ST16)IBA
11/2010
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
06/2010
1Tyrosine (L-Tyrosine)FDA Link
06/2010
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2010
1Aurora Kinase AIBA
06/2010
1ENMD 2076IBA
06/2010
1Phosphotransferases (Kinase)IBA
06/2010
1ferric oxide (iron oxide)IBA
05/2010
1Lactic Acid (Lactate)FDA LinkGeneric
01/2009
1PolyaminesIBA
01/2009
1Citric Acid (Citrate)FDA LinkGeneric
01/2009

Therapy/Procedure

1Chemoprevention
02/2011
1Therapeutics
01/2009